Mohedas, A., Wang, Y., Sanvitale, C., Canning, P., Choi, S., Xing, X., . . . Yu, P. (2014). Structure-activity relationship of 3,5-diaryl-2-aminopyridine ALK2 inhibitors reveals unaltered binding affinity for fibrodysplasia ossificans progressiva causing mutants.
Citazione stile Chigago Style (17a edizione)Mohedas, A., Y. Wang, C. Sanvitale, P. Canning, S. Choi, X. Xing, A. Bullock, G. Cuny, e P. Yu. Structure-activity Relationship of 3,5-diaryl-2-aminopyridine ALK2 Inhibitors Reveals Unaltered Binding Affinity for Fibrodysplasia Ossificans Progressiva Causing Mutants. 2014.
Citatione MLA (9a ed.)Mohedas, A., et al. Structure-activity Relationship of 3,5-diaryl-2-aminopyridine ALK2 Inhibitors Reveals Unaltered Binding Affinity for Fibrodysplasia Ossificans Progressiva Causing Mutants. 2014.